| scholarly article | Q13442814 |
| P2093 | author name string | Bin Xu | |
| Lin Yu | |||
| Li-Zhong Zhao | |||
| P2860 | cites work | Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine | Q26782583 |
| Role of phytochemicals in colorectal cancer prevention | Q26797253 | ||
| Incidence and management of ZIv-aflibercept related toxicities in colorectal cancer | Q26830219 | ||
| A review of conventional and drug-eluting chemoembolization in the treatment of colorectal liver metastases: principles and proof | Q27022812 | ||
| "Adherent" versus Other Isolation Strategies for Expanding Purified, Potent, and Activated Human NK Cells for Cancer Immunotherapy | Q28081338 | ||
| An Intrinsic Mechanism Predisposes Foxp3-Expressing Regulatory T Cells to Th2 Conversion In Vivo | Q28593933 | ||
| Oral tolerance to cancer can be abrogated by T regulatory cell inhibition | Q33618271 | ||
| Insulin-like growth factor-1 regulates the SIRT1-p53 pathway in cellular senescence | Q33986884 | ||
| Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin | Q34626926 | ||
| Identification of DRG-1 As a Melanoma-Associated Antigen Recognized by CD4+ Th1 Cells | Q35628806 | ||
| Th1 Cytokine Production Induced by Lactobacillus acidophilus in BALB/c Mice Bearing Transplanted Breast Tumor. | Q35667803 | ||
| Effective cancer therapy through immunomodulation | Q36366809 | ||
| Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins | Q37163664 | ||
| Inhibition of CD4+CD25+ regulatory T cell function and conversion into Th1-like effectors by a Toll-like receptor-activated dendritic cell vaccine | Q37297514 | ||
| Molecular markers to individualize adjuvant therapy for colon cancer | Q37741795 | ||
| The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance | Q37959968 | ||
| Chemoprevention with phytonutrients and microalgae products in chronic inflammation and colon cancer | Q38013298 | ||
| Central and effector memory CD4 and CD8 T-cell responses to tumor-associated antigens | Q38065308 | ||
| EURECCA consensus conference highlights about colon & rectal cancer multidisciplinary management: the radiology experts review. | Q38179620 | ||
| Th1 cytokine-based immunotherapy for cancer. | Q38259461 | ||
| Th9 cells: a novel CD4 T-cell subset in the immune war against cancer. | Q38318660 | ||
| Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens. | Q38497851 | ||
| MicroRNAs as Regulator of Signaling Networks in Metastatic Colon Cancer | Q40864983 | ||
| Alternatively activated macrophage possess antitumor cytotoxicity that is induced by IL-4 and mediated by arginase-1. | Q42171562 | ||
| Reduced CD18 levels drive regulatory T cell conversion into Th17 cells in the CD18hypo PL/J mouse model of psoriasis | Q45338706 | ||
| Characteristics of immunosuppressive regulatory T cells in cutaneous squamous cell carcinomas and role in metastasis | Q48020355 | ||
| Correlation of survivin, p53 and Ki-67 in laryngeal cancer Hep-2 cell proliferation and invasion. | Q51790283 | ||
| Curcumin inhibits suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro | Q56897901 | ||
| Prevalence of colorectal adenoma in an average-risk population aged 40-50 versus 50-60 years | Q85929177 | ||
| Myeloid-derived suppressor cells attenuate TH1 development through IL-6 production to promote tumor progression | Q87774090 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | curcumin | Q312266 |
| P304 | page(s) | 1866-1875 | |
| P577 | publication date | 2017-04-15 | |
| P1433 | published in | American Journal of Translational Research | Q4744272 |
| P1476 | title | Curcumin up regulates T helper 1 cells in patients with colon cancer | |
| P478 | volume | 9 |
| Q61449208 | A Phase 2 Study to Assess the Immunomodulatory Capacity of a Lecithin-based Delivery System of Curcumin in Endometrial Cancer |
| Q47136685 | Curcumin Suppresses the Colon Cancer Proliferation by Inhibiting Wnt/β-Catenin Pathways via miR-130a |
| Q89844461 | Curcumin and colorectal cancer: An update and current perspective on this natural medicine |
| Q92636408 | Curcumin-Mediated Apoptotic Cell Death in Papillary Thyroid Cancer and Cancer Stem-Like Cells through Targeting of the JAK/STAT3 Signaling Pathway |
| Q58541822 | Efficacy of bio-optimized extracts of turmeric and essential fennel oil on the quality of life in patients with irritable bowel syndrome |
| Q90397109 | Natural Compounds with Potential to Modulate Cancer Therapies and Self-Reactive Immune Cells |
| Q64069620 | Polyphenols as Immunomodulatory Compounds in the Tumor Microenvironment: Friends or Foes? |
| Q52320729 | Strategy to targeting the immune resistance and novel therapy in colorectal cancer. |
| Q64229427 | Targeting Immune-Related Molecules in Cancer Therapy: A Comprehensive Analysis on Patient-Derived Tumor Models |
| Q91839819 | The immunomodulatory potential of natural compounds in tumor-bearing mice and humans |
| Q91639454 | The roles of curcumin in regulating the tumor immunosuppressive microenvironment |
| Q92839407 | Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science |
Search more.